CD155, an immunoglobulin-like adhesion molecule, has been proved upregulated in a series of human malignancies, such as colon cancer, lung adenocarcinoma, melanoma, pancreatic cancer and glioblastoma 12, 29-32. This evidence concerns the gene PVR and pancreatic neoplasm.